- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01536782
Optimal Tube Feeding Method in Head and Neck Cancer Patients
The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is a great challenge to maintain the nutritional status of the head and neck cancer (HNC) patients through treatment advances such as combined chemoradiation therapy or CRT. For all these reasons, HNC patients undergoing treatment, frequently require alternate methods of nutrition support such as as enteral tube feeding via a gastrostomy tube.Upon gastric tube feeding initiation, the registered dietitian (RD) must consider the three different methods: bolus (using a syringe), gravity (using gravity feeding bags), and pump (using a tube feeding pump).
Typically, patients are started on bolus (OPTION A), changed to gravity (OPTION B) if bolus feeds are not tolerated, and ultimately changed to pump (OPTION C) if gravity feeds are not tolerated. The concern is that in this process of starting with OPTION A, and moving to OPTION B or further to OPTION C, the patient may experience unintentional weight loss and dehydration related to tube feeding intolerance and/or tube feeding inadequacy. Consequently, this places the patient at risk of, but not limited to, hospital admission for dehydration and/or malnutrition, and treatment interruption. Therefore, exploring the idea of an optimal feeding method and starting patients on it from the beginning, may improve patient outcomes in terms of nutritional status.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75246
- Charles A. Sammons Cancer Center at Baylor University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Males and females
- 18 years or older
- Diagnosis of SCCHN undergoing concurrent chemoradiation therapy (including patients who received induction therapy upfront
Exclusion Criteria:
- Patients who have a small bowel feeding tube (only tube feeding via pump is allowed in this case)
- Patients with history of gastric surgery which may have resulted in altered gastrointestinal function
- Patients with history of uncontrolled diabetes and/or gastroparesis which may interfere with gastric emptying and inability to tolerate bolus feeds
- Patients at high risk of aspiration in which case slower feeds by using gravity or pump are indicated
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Bolus
Upon tube feeding initiation determined by the HNC multidisciplinary team, the patients will be randomized into three different groups, each consisting of 20 patients each: Bolus (Group 1), Gravity (Group 2), and Pump (Group 3).
The randomization process within these three groups will based on 1) age and 2) estimated caloric need.
For example, if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either Bolus, Gravity or Pump group.
Another example is that if we have two 45-year-old patients whose estimated needs are 2400kcals/day, then one patient will randomly be assigned to the Bolus group, and the other one will be randomly assigned to the Gravity group.
The third patient that will fit that category will be assigned to the Pump group.
|
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly. |
|
Active Comparator: Gravity
Upon tube feeding initiation determined by the HNC multidisciplinary team, the patients will be randomized into three different groups, each consisting of 20 patients each: Bolus (Group 1), Gravity (Group 2), and Pump (Group 3).
The randomization process within these three groups will based on 1) age and 2) estimated caloric need.
For example, if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either Bolus, Gravity or Pump group.
Another example is that if we have two 45-year-old patients whose estimated needs are 2400kcals/day, then one patient will randomly be assigned to the Bolus group, and the other one will be randomly assigned to the Gravity group.
The third patient that will fit that category will be assigned to the Pump group.
|
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly. |
|
Active Comparator: Pump
Upon tube feeding initiation determined by the HNC multidisciplinary team, the patients will be randomized into three different groups, each consisting of 20 patients each: Bolus (Group 1), Gravity (Group 2), and Pump (Group 3).
The randomization process within these three groups will based on 1) age and 2) estimated caloric need.
For example, if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either Bolus, Gravity or Pump group.
Another example is that if we have two 45-year-old patients whose estimated needs are 2400kcals/day, then one patient will randomly be assigned to the Bolus group, and the other one will be randomly assigned to the Gravity group.
The third patient that will fit that category will be assigned to the Pump group.
|
The patients will be randomized into 3 different groups: Bolus, Gravity, and Pump. The randomization process will be based on age and estimated caloric needs (i.e if we have three 60-year-old patients whose estimated kcals needs are ≤ 1900kcals/day, then each patient will be randomized to either of the groups). Each patient from each group will be receiving tube feeding education to their by RD. For consistency reasons, the same type of tube feeding formula (1.5 kcal/ml, no fiber) will be used. Patients' weight, tube feeding tolerance, and amount of estimated calories and protein met will be monitored weekly. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
percent weight loss
Time Frame: 2 years
|
2 years
|
|
tolerance of enteral feedings
Time Frame: 2 Years
|
2 Years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent met of estimated calories and proteins
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andreea Nguyen, MS in Nutrition, Baylor Health Care System
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- head and neck cancer
- chemoradiation therapy
- bolus feeding
- gravity feeding
- pump feeding
- optimal enteral feeding method
- To determine the optimal tube feeding method by analyzing percent weigtht loss.
- To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
- To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
Additional Relevant MeSH Terms
Other Study ID Numbers
- 012-026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)RecruitingAdvanced Head and Neck CancerCanada
-
Centre Oscar LambretCompletedEpidermoid Head and Neck CancerFrance
-
Radboud University Medical CenterUnknown
-
University of California, San FranciscoCompleted
Clinical Trials on Bolus
-
AC Camargo Cancer CenterCompletedBreast Cancer | RadiodermatitisBrazil
-
Rob RutledgeNova Scotia Health AuthorityCompletedBreast CancerCanada
-
Providence University, TaiwanUnknown
-
Tulane UniversityWithdrawnRadiotherapyUnited States
-
Guang'anmen Hospital of China Academy of Chinese...Not yet recruitingKnee Osteoarthritis (Knee OA)
-
Rawalpindi Medical CollegeRecruitingPhenylephrine | Cesarean BirthPakistan
-
Rabin Medical CenterCompleted
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedAcute Decompensated Heart Failure (ADHF)Turkey (Türkiye)
-
Tartu University HospitalEstonian Research CouncilUnknown
-
University Hospital, ToulouseCompleted